These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23952887)

  • 1. Acceptability of contingency management among clinicians and clients within a co-occurring mental health and substance use treatment program.
    Srebnik D; Sugar A; Coblentz P; McDonell MG; Angelo F; Lowe JM; Ries RK; Roll J
    Am J Addict; 2013; 22(5):432-6. PubMed ID: 23952887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
    Aletraris L; Shelton JS; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():41-8. PubMed ID: 26001821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.
    Davis AK; Rosenberg H; Rosansky JA
    J Subst Abuse Treat; 2017 Nov; 82():29-33. PubMed ID: 29021112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counselor and client characteristics in mental health versus substance abuse treatment settings providing services for co-occurring disorders.
    Mangrum LF; Spence RT
    Community Ment Health J; 2008 Jun; 44(3):155-69. PubMed ID: 18071898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing routine chronic disease preventive care in community substance use services: a pilot study of a multistrategic clinical practice change intervention.
    Tremain D; Freund M; Wye P; Bowman J; Wolfenden L; Dunlop A; Bartlem K; Lecathelinais C; Wiggers J
    BMJ Open; 2018 Aug; 8(8):e020042. PubMed ID: 30121589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.
    Lee MT; Acevedo A; Garnick DW; Horgan CM; Panas L; Ritter GA; Campbell KM
    Psychiatr Serv; 2018 Jul; 69(7):804-811. PubMed ID: 29695226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward evidence-based pharmacological treatments among community-based addiction treatment programs targeting vulnerable patient groups.
    Krull I; Lundgren L; Zerden Lde S
    J Addict Dis; 2011 Oct; 30(4):323-33. PubMed ID: 22026524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.
    Kirby KC; Benishek LA; Dugosh KL; Kerwin ME
    Drug Alcohol Depend; 2006 Oct; 85(1):19-27. PubMed ID: 16650657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to serving clients with co-occurring disorders in a transformed mental health system.
    Padwa H; Guerrero EG; Braslow JT; Fenwick KM
    Psychiatr Serv; 2015 May; 66(5):547-50. PubMed ID: 25686812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severely mentally ill consumers' perspectives on drug use.
    Alvidrez J; Kaiser D; Havassy BE
    J Psychoactive Drugs; 2004 Sep; 36(3):347-55. PubMed ID: 15559681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders.
    Rosenberg SD; Drake RE; Brunette MF; Wolford GL; Marsh BJ
    AIDS; 2005 Oct; 19 Suppl 3():S26-33. PubMed ID: 16251824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating substance abuse and mental health issues as 'mutually-exclusive' entities: Best practice or an outmoded approach to intervention?
    Webber A; Clark J; Kelly D
    Int J Ment Health Nurs; 2016 Feb; 25(1):27-32. PubMed ID: 26777611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.
    Murphy SM; McDonell MG; McPherson S; Srebnik D; Angelo F; Roll JM; Ries RK
    Drug Alcohol Depend; 2015 Aug; 153():293-9. PubMed ID: 26026494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurring disorders in the adolescent mental health and substance abuse treatment systems.
    Turner WC; Muck RD; Muck RJ; Stephens RL; Sukumar B
    J Psychoactive Drugs; 2004 Dec; 36(4):455-62. PubMed ID: 15751483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid pathological gambling, mental health, and substance use disorders: Health-care services provision by clinician specialty.
    Rodriguez-Monguio R; Errea M; Volberg R
    J Behav Addict; 2017 Sep; 6(3):406-415. PubMed ID: 28856904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Training substance abuse treatment staff to care for co-occurring disorders.
    Hunter SB; Watkins KE; Wenzel S; Gilmore J; Sheehe J; Griffin B
    J Subst Abuse Treat; 2005 Apr; 28(3):239-45. PubMed ID: 15857724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.